4//SEC Filing
Sumner Michael John 4
Accession 0001055726-23-000045
CIK 0001055726other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:12 PM ET
Size
7.2 KB
Accession
0001055726-23-000045
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-06-30−35,000→ 70,000 total→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2023-06-30+35,000→ 35,000 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 105,000 restricted stock units is as follows: 35,000 shares vested on June 30, 2023; 35,000 shares will vest on June 30, 2024; 35,000 shares will vest on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001936799
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:12 PM ET
- Size
- 7.2 KB